Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

Author： Bisaga A. Popik P. Bespalov A.Y. Danysz W.

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.10, 2000-10, pp. : 2233-2248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E. Noll G. Lüscher T.F.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite

Potential of Adenosine A Receptor Antagonists in the Treatment of Movement Disorders

By Mally J.

CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 311-320

Adis International

Access to resources Recommend Favorite

Substance P Receptor Antagonists in Psychiatry: Rationale for Development and Therapeutic Potential

By Herpfer Inga Lieb Klaus

CNS Drugs, Vol. 19, Iss. 4, 2005-01 ,pp. : 275-293

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of 5-HT2C Receptor Antagonists in the Treatment of Anxiety Disorders

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 6, 2003-12 ,pp. : 383-387

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Cytokine Receptor Antagonists as Potential Therapeutic Agents for the Myeloproliferative Disorders

Current Pharmaceutical Design, Vol. 8, Iss. 5, 2002-03 ,pp. : 357-368

Bentham Science Publishers

Access to resources Recommend Favorite